Upcoming events and latest news.
Dr. Heli Nevanlinna and the Hereditary Breast Cancer Research Group was awarded a 2-year research grant of 150 000 € by Cancer Foundation Finland for genetic modeling of breast cancer survival.
MSc Taru Muranen successfully defended her doctoral dissertation titled "Genetic modifiers of CHEK2-associated and familial breast cancer".
MSc Johanna Kiiski successfully defended her doctoral dissertation titled "FANCM mutations in breast cancer risk and survival".
MSc Liisa Pelttari successfully defended her doctoral dissertation titled "Genetics of breast and ovarian cancer predisposition with a focus on RAD51C and RAD51D genes".
BCAC - CIMBA - ENIGMA Consortia meetings, April 2019, Springdale, UT, US